Viewing Study NCT00048659

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:39 PM
Ignite Modification Date: 2026-01-27 @ 5:28 AM
Study NCT ID: NCT00048659
Status: TERMINATED
Last Update Posted: 2012-06-07
First Post: 2002-11-04
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy
Sponsor: Astellas Pharma Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hormone-Refractory Prostate Cancer View
None Prostatic Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Androgen-independent prostate cancer View